Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. - Lustig M; Kowol M; Hartmann AM; van der Peet IC; Jansen MJH; Iben K; Winterberg D; Krohn S; Baumann N; Rösner T; Bendig S; Hahn C; et al. (Blood neoplasia, 2026)